Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT00156858
Status:
UNKNOWN
Last Update Posted:
2012-01-19
First Post:
2005-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D019337', 'term': 'Hematologic Neoplasms'}], 'ancestors': [{'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D006402', 'term': 'Hematologic Diseases'}, {'id': 'D006425', 'term': 'Hemic and Lymphatic Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NON_RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 200}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '1998-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-09', 'completionDateStruct': {'date': '2010-12'}, 'lastUpdateSubmitDate': '2012-01-18', 'studyFirstSubmitDate': '2005-09-08', 'studyFirstSubmitQcDate': '2005-09-08', 'lastUpdatePostDateStruct': {'date': '2012-01-19', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2005-09-12', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'pharmacokinetic data'}]}, 'conditionsModule': {'keywords': ['pharmacokinetics', 'transplantation', 'busulfan'], 'conditions': ['Hematologic Malignancy']}, 'descriptionModule': {'briefSummary': 'A study of pharmacokinetics of daily intravenous busulfan', 'detailedDescription': 'A study of pharmacokinetics of daily intravenous busulfan'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* patients undergoing transplantation\n\nExclusion Criteria:\n\n\\-'}, 'identificationModule': {'nctId': 'NCT00156858', 'briefTitle': 'Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study', 'organization': {'class': 'OTHER', 'fullName': 'AHS Cancer Control Alberta'}, 'officialTitle': 'Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell', 'orgStudyIdInfo': {'id': '10156'}, 'secondaryIdInfos': [{'id': '717905172'}]}, 'armsInterventionsModule': {'interventions': [{'name': 'intravenous busulfan', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'zip': 'T2N 4N2', 'city': 'Calgary', 'state': 'Alberta', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Rachel Syme, PhD', 'role': 'CONTACT', 'email': 'clinical_trials_tbcc@cancerboard.ab.ca'}, {'name': 'Chris Brown', 'role': 'SUB_INVESTIGATOR'}, {'name': 'Ron Anderson', 'role': 'SUB_INVESTIGATOR'}, {'name': 'James Russell', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Victor Lewis', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'Tom Baker Cancer Centre', 'geoPoint': {'lat': 51.05011, 'lon': -114.08529}}], 'overallOfficials': [{'name': 'James Russell, FRCp', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Alberta Cancerboard'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Alberta Health services', 'class': 'OTHER'}}}}